Next Article in Journal
Targeting Signalling Pathways in Chronic Wound Healing
Next Article in Special Issue
A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall Imaging
Previous Article in Journal
To Gain Insights into the Pathophysiological Mechanisms of the Thrombo-Inflammatory Process in the Atherosclerotic Plaque
Previous Article in Special Issue
The Haptoglobin Response after Aneurysmal Subarachnoid Haemorrhage
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 25
Issue 1
10.3390/ijms25010048
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of Gut and Oral Microbiota in the Formation and Rupture of Intracranial Aneurysms: A Literature Review

by
Ann-Kathrin Joerger
1,
Carolin Albrecht
1,
Veit Rothhammer
2,
Klaus Neuhaus
3,
Arthur Wagner
1,
Bernhard Meyer
1 and
Maria Wostrack
1,*
1
Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany
2
Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, 91054 Erlangen, Germany
3
Core Facility Microbiom, ZIEL Institute for Food & Health, Technical University of Munich, 85354 Freising, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(1), 48; https://doi.org/10.3390/ijms25010048
Submission received: 12 November 2023 / Revised: 14 December 2023 / Accepted: 18 December 2023 / Published: 19 December 2023
(This article belongs to the Special Issue New Trends in Molecular Research of Aneurysm and Brain Injury)
Browse Figure
Versions Notes

Abstract

:
In recent years, there has been a growing interest in the role of the microbiome in cardiovascular and cerebrovascular diseases. Emerging research highlights the potential role of the microbiome in intracranial aneurysm (IA) formation and rupture, particularly in relation to inflammation. In this review, we aim to explore the existing literature regarding the influence of the gut and oral microbiome on IA formation and rupture. In the first section, we provide background information, elucidating the connection between inflammation and aneurysm formation and presenting potential mechanisms of gut–brain interaction. Additionally, we explain the methods for microbiome analysis. The second section reviews existing studies that investigate the relationship between the gut and oral microbiome and IAs. We conclude with a prospective overview, highlighting the extent to which the microbiome is already therapeutically utilized in other fields. Furthermore, we address the challenges associated with the context of IAs that still need to be overcome.

1. Introduction

Subarachnoid hemorrhage (SAH) resulting from the rupture of an intracranial aneurysm (IA) is a devastating type of stroke affecting around 6/100,000 patients worldwide annually [1], leading to high mortality and morbidity rates [2,3]. It harbors a case fatality rate of 50% [4]. Due to the young age of onset compared to ischemic stroke and intracerebral hemorrhage, SAH is a major contributor to the stroke-related loss of productive life years despite advancements in risk assessment, imaging techniques, and surgical and intensive care treatment [2,3]. Most SAH survivors suffer from persistent, disabling neurological deficits; even those who experience some degree of neurological recovery often face ongoing psychological and cognitive impairments. As a result, 46% of SAH survivors remain severely disabled in their activities of daily life and are unable to return to work, resulting in a considerable socioeconomic burden [3,5]. Approximately 3% of the population harbors an incidental IA, but only a minority will experience a rupture leading to aneurysmal SAH [6]. While various risk factors for IA rupture have been identified, including smoking, prior SAH, hypertension, hypercholesterolemia, age, gender, aneurysm location, aneurysm size, heart disease, and aspirin use [7,8,9,10,11,12], their respective individual impact is far from being fully investigated [13,14,15].
In recent years, there has been a growing interest in the role of the microbiome in cardiovascular and cerebrovascular diseases [16,17,18,19,20,21,22]. The “microbiome” encompasses all microorganisms residing in or on various parts of the human body, which includes bacteria, fungi, and viruses (and all of their genes). The gut microbiome is particularly susceptible to modulation by dietary habits, lifestyle, and environmental factors [23]. The role of diet as a risk factor for cardiovascular events has been shown before [24]. More recently, attention has turned to the intestinal microbiome’s role in this process, with certain dietary components, such as carnitine from red meat and phosphatidylcholine from egg yolk, being metabolized by gut bacteria into trimethylamine, eventually converted in the liver into trimethylamine n-oxide (TMAO), which has been established as a risk factor for atherosclerosis [25,26]. For aortic aneurysms there is growing evidence about a potential role of the gut microbiome in formation and rupture [21,27,28,29]. For example, it was shown that patients with Campylobacter gracilis or Fusobacterium in their gut microbiome had a significantly higher incidence of aortic aneurysm-related events [27].
Moreover, the hypothesis exists that the microbiome regulates intracranial processes like neuroinflammation, brain injury, autoimmunity, and neurogenesis via the activation of innate and adaptive immune cells [30]. Several studies have demonstrated the crucial pathophysiological role of inflammation in the formation and rupture of IAs [31,32]. By modulating vascular inflammation, microbiota may exert both beneficial and detrimental effects on the development and rupture of IAs. It is worth noting that a substantial microbiome also exists in the oral cavity which could play a role in IA formation and rupture. So far, only a few studies have investigated the correlation between the microbiome and IAs. In this narrative review, we aim to explore the existing literature regarding the influence of the gut and oral microbiome on IA formation and rupture.

2. Exploring Pathways: Inflammation and Cerebral Aneurysm Formation, Gut–Brain Interactions, and Microbiome Analysis

2.1. The Role of Inflammation in Cerebral Aneurysm Formation

Increasing evidence suggests that inflammation plays a pivotal role in the formation of IAs [33]. This process includes endothelial dysfunction, followed by an inflammatory response, the phenotype shift of smooth muscle cells (SMCs), the remodeling of the extracellular matrix, and ultimately, cell death and degradation of the vessel wall [34,35]. The initial cause of endothelial dysfunction and subsequent vascular remodeling is the result of wall shear stress [36]. It was shown that areas of high wall shear stress, such as the apex of an arterial bifurcation, are especially predisposed to aneurysm formation [37]. Mechanical shear stress upregulates the expression of pro-inflammatory mediators, such as the nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB) [38], matrix metalloproteinases (MMPs) [39], interleukin-1β (IL-1β) [40], Ets-1, and monocyte chemoattractant protein-1 (MCP-1) [41] and downregulates the expression of anti-inflammatory mediators, such as nitric oxide (NO) [40] in endothelial cells. Pro-inflammatory mediators activate the inflammatory response, in which macrophages play a pivotal role [33]. Macrophages not only release pro-inflammatory cytokines that attract more inflammatory cells, but also secrete MMPs that break down the extracellular matrix of the arterial wall, causing additional damage by promoting the activation of other proteinases. For rats, it was shown that the presence of macrophages and their derived MMPs was closely linked to IA growth, and that the inhibition of these MMPs haltered the progression of IAs [42]. Similarly, Kanematsu et al. [32] found that mice depleted of macrophages had a significantly reduced risk of developing IAs. Moreover, inhibiting MCP-1, a chemokine that controls the infiltration of macrophages, prevented the development of IAs in mice [43].
Macrophages are not the sole cells participating in the inflammatory response within the IA wall. Frosen et al. [44] reported in their study, which compared 42 ruptured and 24 unruptured IAs using a histological analysis, that the infiltration of the vessel wall by both macrophages and T cells was associated with aneurysm rupture. Moreover, mast cells may also play a role in IA formation. In rats, an elevated presence of mast cells during IA formation was noted [45]. Additionally, the advancement of IA was effectively halted when a mast cell degranulation inhibitor was administered.
SMCs, primarily located in the media layer of vessels, are the primary cells responsible for producing the extracellular matrix in the vascular wall [33]. During the early stages of aneurysm formation, SMCs migrate from the media layer into the intima layer in response to endothelial injury and undergo proliferation, resulting in myointimal hyperplasia. As the process continues, SMCs undergo a phenotypic shift from a specialized phenotype focused on contraction to a dedifferentiated phenotype, which contributes to inflammation and the breakdown of the extracellular matrix by expressing pro-inflammatory mediators and MMPs [34]. Morphologically, these dedifferentiated SMCs no longer maintain their tightly compacted spindle-like arrangement, but instead separate from each other and take on a spider-like appearance within the aneurysm walls, leading to remodeling [46].
MMPs are observed to be produced by both macrophages [42] and SMCs [45] within the wall of the blood vessels or aneurysms. These MMPs play a role in breaking down the extracellular matrix of the arterial wall, leading to additional damage through the upregulation of other proteinases and angiogenic factors [47].
Given this crucial role of inflammation in the pathophysiology of IA formation, the gut and oral microbiome could also be involved in this process by modulating the inflammatory response.

2.2. Potential Mechanisms of Gut–Brain Interaction

In rats, after ischemic stroke, an intestinal dysregulation with a greater permeability of the gut-blood barrier has been shown [48]. Consecutively, lipopolysaccharide (LPS) from Gram-negative bacteria of the intestine is translocated to the systemic circulation [49], activating inflammatory processes. Following cerebral ischemia, the disruption of the blood-brain barrier permits the entry of LPS into the brain parenchyma. This, in turn, triggers the activation of Toll-like receptor 4 (TLR4) and the release of inflammatory cytokines, further intensifying the damage to the ischemic brain [50]. Not only after ischemic stroke, but also after intracerebral hemorrhage (ICH), intestinal permeability increased in mice [51]. Moreover, T cells and monocytes originating from intestinal Peyer’s patches accumulated in the intracerebral hematoma. The expression of pro-inflammatory markers like IL-1β, inducible nitric oxide synthase, and tumor necrosis factor α (TNF-α) was significantly elevated in the brain tissue, while this was reversed after fecal microbiota transplantation.
For IA formation, the gut–brain interaction still remains unclear. A direct translocation of bacteria or LPS to the IAs appears unlikely [52]; instead, an indirect mechanism modulating the inflammatory response in the aneurysm wall is proposed [53] (Figure 1). Other potential mechanisms of gut–brain interaction include the direct stimulation of the enteric and autonomic nervous system, neuroendocrine pathways, and the production of biochemical (neuro-)transmitters by microbiota [49].

2.3. Methods of Analyzing the Microbiome

The two currently predominant approaches for microbial identification in microbiome samples involve the next-generation sequencing (NGS) of gene amplicons from marker genes, such as 16S rRNA, or shotgun metagenomics [54].
16S-rRNA gene amplicon sequencing: This approach is a targeted approach, i.e., with the help of the polymerase chain reaction (PCR), a marker gene of interest is amplified. The amplicons are then sequenced in high throughput and the sequences are used to identify an organism. The primary target for bacterial identification is normally the 16S-rRNA gene [54]. Due to its critical role in the ribosome, it is a well-conserved gene and suitable for the taxonomic classification of bacteria [55]. The 16S-rRNA gene sequence can be divided into invariable regions and nine variable regions (V1–V9). PCR is used with specific primers, which bind in the conserved regions. However, the most-used current sequencing machines only cover 2 × 300 bp, and therefore, only one to three (adjacent) variable regions are amplified. In the medical context, many 16S rRNA-based genotyping protocols focus on V1–V3, V3–V4, or the V4 regions, while, for instance, V5–V6 or V6–V8 are used more often in other fields (e.g., soil samples). Of note, despite their name, the invariable regions are also not completely fixed and primer bias occurs, since some primers may or may not bind certain taxa [56]. Novel long-read sequencers may cover the entire length of the 16S-rRNA gene, which can increase species-level resolution [57]. In any case, after sequencing, the data are used to identify and categorize microbial profiles for alpha and beta diversity and further advanced analyses (see [58] on Type 2 diabetes as example). Finally, a note of caution. Detecting bacteria, which may cause aneurysms but are only present in low numbers using an amplicon-based approach, is challenging [59,60]. For instance, the placenta microbiome has turned out to be purely due to contamination [61]. Future research must therefore use proper controls and care to avoid false conclusions.
Metagenome sequencing: This approach is an untargeted approach; i.e., where possible, the complete DNA of a given sample is isolated, fragmented, and sequenced (shotgun sequencing; [54]). Due to its untargeted nature, it could, in principle, detect all organisms present; however, this is limited by sequencing depth. For instance, biopsies might contain too-low numbers of bacteria and their DNA is “drowned” in human DNA. In contrast, in stool samples, where primarily only bacteria are found, one can uncover the genes, pathways, and metabolic functions existing within the community [62]. However, this still is limited, since the function of about 40–60% of the genes present in a given sample cannot be functionally predicted [63]. Nevertheless, deep-sequenced metagenome samples are certainly helpful in detecting bacteria, which might cause or have caused an aneurysm (see below).

3. The Gut Microbiome and Intracranial Aneurysm Formation and Rupture

While several studies have investigated the microbiome’s influence on stroke [17,18,19,64], there are limited data on the role of the microbiome in IA formation and rupture. The studies discussed here are depicted in Table 1.
Table 1. Overview of studies on the gut microbiome and IAs.
Table 1. Overview of studies on the gut microbiome and IAs.
StudyTypeMediumInterventionAimMethodResult
Shikata et al., 2019 [52]interventional studymicegut depletion by antibiotics in mice with IA induction vs. mice with normal gut and IA induction- number and rupture rate of IAs;
- number of macrophages in IA tissue;
- mRNA levels of cytokines in IA tissue.		- immunohistochemistry;
- RT-PCR.		- gut depletion reduced the incidence of IA (83% vs. 6%, p < 0.001) and rupture;
- macrophage infiltration and mRNA levels of inflammatory cytokines were reduced with gut depletion.
Li et al., 2020 [65]case–control study- humans
- mice		- analysis of fecal samples of 140 UIA and 140 control patients;
- 20 mice treated with UIA patient feces and 20 treated
with control feces.		- comparison of gut microbiome of patients with UIAs and without;
- test, if changes in the gut microbiota influence the progression of UIAs in vivo.		- metagenomic shotgun sequencing;
- serum metabolomic analysis.		- Bacteroides ssp., Odoribacter splanchnicus, Clostridium ssp. were significantly enriched in the UIAs;
- Hungatella hathewayi was enriched in the control group;
- microbiome of UIAs was significantly dominated by unsaturated fatty acid biosynthesis;
- microbiome of controls was dominated by amino acid synthesis;
- treatment with feces from UIA patients increased the overall incidence of IAs (85% vs. 45%; p = 0.019) and rupture rate (82% vs. 22%; p = 0.009);
- serum concentrations of 2 of 8 fatty acids and 8 of 38 amino acids differed in mice transplanted with feces from UIA patients and controls.
Kawabata et al., 2022. [66]multicenter, prospective case–controlhumansanalysis of fecal samples of 28 RAs vs. 33 UIAscomparison of gut microbiome of patients with UIAs and RAs 16S rRNA sequencing- gut microbiome profile of UIAs and RAs were significantly different;
- Campylobacter ssp. and Campylobacter ureolyticus were significantly higher in the RA group.
He et al., 2023.
[67]		two-sample Mendelian
randomization study		humansdatabase analysis of gut microbiome of patients with IA, UIA, SAHassociation between the gut microbiome and the risk of
IA, UIA, and SAH		inverse variance weighting approach- Candidatus Soleaferrea decreased the risk of IA;
- Holdemania and Olsenella increased risk of IA;
- Lentisphaeria, Porphyromonadaceae, Bilophila, Fusicatenibacter, Ruminococcus sp. 1,
Victivallales decreased risk of SAH;
- Streptococcaceae increased risk of SAH;
- Porphyromonadaceae, Bilophila decreased the risk of UIA;
- Oxalobacteraceae, Adlercreutzia,
Intestinimonas, Victivallis increased the risk of UIA.
Ma et al., 2023.
[68]		two-sample Mendelian
randomization study		humansdatabase analysis of gut microbiome of UIA patientsassociation between the gut microbiome and the risk of
UIA		inverse variance weighting approach- Clostridia, Rhodospirillaceae, Adlercreutzia, Sutterella, Victivallis, Streptococcus, Peptostreptococcaceae increased risk of UIA;
- Oscillospira, Paraprevotella decreased the risk of UIA.
IA = intracranial aneurysm, UIA = unruptured intracranial aneurysm, RA = ruptured intracranial aneurysm, SAH = subarachnoid hemorrhage, RT-PCR = real time polymerase chain reaction, sp. = species (sg.); ssp. = species (pl.).
Kawabata et al. [66] observed significant differences in the gut microbiome between patients with unruptured intracranial aneurysms (UIAs) and those with ruptured intracranial aneurysms (RAs). The relative abundance of Campylobacter, especially Campylobacter ureolyticus, was larger in the RA group compared to the UIA group [66]. Nevertheless, it is well-established that brain injuries, such as ischemic stroke and ICH, can already have an impact on the gut microbiome [69], which raises uncertainty about whether the distinctions between the groups were influenced by the stress associated with SAH or had already manifested prior to the onset of SAH. A cause–effect relationship between Campylobacter and aneurysm rupture could not be shown.
In a database analysis of the gut microbiome of patients with UIAs and Ras, He et al. [67] identified three bacterial traits causally related to IAs and six bacterial traits related to UIAs (Table 1). Six bacterial traits were causally related to a decreased risk of subarachnoid hemorrhage (SAH) (Table 1).
Another Mendelian randomization study by Ma et al. [68] indicated bacteria with beneficial and detrimental effects on IAs as well (Table 1). However, both studies did not reflect other individual risk factors.
Nevertheless, these three studies reveal significant differences in the composition of the microbiome between patients with unruptured and ruptured IAs. They can even identify specific protective or non-protective bacterial species, suggesting that certain microbiome compositions could potentially serve as biomarkers for the risk of an aneurysm rupture in the future. However, correlation does not automatically imply causation. To identify biomarkers in the microbiome for the multifactorial event of a ruptured IA, it is necessary to explore the causes of the observed changes in the microbiome, to understand the mechanisms of signaling and interaction of the microbiome and the host, and to take into account ethnic variations in the composition of the microbiome [70] and other patient-specific risk factors.
Li et al. [65] observed that patients with UIAs had significant differences in their microbiome composition compared to healthy patients. They also found differences in metabolic pathways in the microbiome and differences in circulating amino acids between UIA patients and healthy controls. Moreover, transplanting feces from UIA patients into mice increased the incidence and rupture rate of IAs compared to mice treated with control feces, while supplementation with taurine significantly reduced the aneurysm formation and rupture rate. This study strongly indicates a role of the microbiome and of taurine on the formation and rupture of IAs. However, the exact mechanism could not be identified. Moreover, results from mice models should be transferred to the more complex human context extremely carefully.
Shikata et al. [52] demonstrated that gut depletion by antibiotics significantly reduced the incidence and rupture rate of IAs in mice, accompanied by a decrease in macrophages within the aneurysm wall and reduced levels of IL-1β, IL-6, and inducible nitric oxide synthase. Undoubtedly, this study indicates an influence of the microbiome on the development of IAs and the associated inflammatory response. However, the following aspects should be discussed: (I) The authors themselves acknowledge that they cannot explain the exact mechanism through which the microbiome affects IA formation. They could only rule out a direct migration of the bacteria into the cerebral arteries, as they did not find any bacterial DNA in the vessels. (II) The gut microbiota was eliminated by a combination of four antibiotics. However, these drugs themselves could have an influence on IA formation and the observed inflammatory response. (III) Antibiotic application not only depletes the gut microbiome but also microbiota in other sites, which also could contribute to the observed effects. (IV) Results from mice models are generated in a highly controlled setting that should be kept in mind when extrapolating the results to patients in a much more complex setting.

4. The Oral Microbiome and Intracranial Aneurysm Formation and Rupture

The literature on the role of the oral microbiome in intracranial aneurysm formation is limited. Table 2 gives an overview.
Table 2. Overview of studies on the oral microbiome and IAs.
Table 2. Overview of studies on the oral microbiome and IAs.
StudyTypeMediumInterventionAimMethodResult
Pyysalo et al., 2013. [71]prospective cohort studyhumansanalysis of RA tissue of 36 patients with SAHassess the presence of oral and pharyngeal bacterial
genome in RAs		qRT-PCR- bacterial DNA was detected in 21/36 (58%);
- DNA from endodontic bacteria was detected in 20/36 (56%) and from periodontal bacteria in 17/36 (47%);
- DNA of the Streptococcus-mitis group was the most common.
Pyysalo et al., 2016. [72]prospective cohort studyhumansanalysis of RA tissue of 42 patients and UIA tissue of 28 patients, tissue from healthy vessels and cardiac by-pass operations as controlsassess the presence of oral and pharyngeal bacterial DNA in RAs and UIAsqRT-PCR- bacterial DNA was detected in 49/70 (70%);
- 29/42 (69%) of the RA tissue and 20/28 (71%) of the UIA tissue contained bacterial DNA of oral origin;
- RA and UIA samples contained significantly more bacterial DNA than control samples.
Pyysalo et al., 2018. [73]prospective cohort studyhumansanalysis of tissue from gingival pockets of 30 patients with RA and 60 with UIAassess the presence of dental infectious foci and odontogenic bacteria in patients
before surgical treatment of IA		qRT-PCR- total of 43% had gingival pockets of 6 mm or deeper;
- bacterial and Fusobacterium nucleatum DNA were significantly higher in the patients with ≥6 mm gingival pockets than patients without them.
Inenaga et al., 2018. [74]prospective cohort studyhumansanalysis of saliva from 48 patients with CES, 151 with non-CES infarct, 54 with ICH, 43 with RA, and 97 with UIA vs. 79 healthy controlsassess the rate of Streptococcus mutans
with collagen-binding protein, Cnm, in CES, non-CES infarct, ICH, RA, and UIA		PCR- significantly high Cnm-positive rate was observed in CES, non-CES infarct, ICH and RA compared to controls.
Aboukais et al., 2019. [75]prospective cohort studyhumansanalysis of IA tissue from 10 patients with RA and 20 with UIA, samples from STA, dura mater, and MCA as controlassess the presence of bacteria in the walls of UIAs and RAsPCR- no bacterial presence was found in the wall of aneurysms.
Hallikainen et al., 2019. [76]case series, case–control, prospective studyhumansoral examination of
42 patients with UIAs and 34 RAs compared to 5170 from prospective database		association of periodontitis with IA formation and SAHmultivariate logistic regression- periodontitis, severe periodontitis, and gingival bleeding increased the risk of IAs significantly;
severe periodontitis in ≥3 teeth or gingival bleeding increased the risk of SAH significantly.
Hallikainen et al., 2021. [77]prospective cohort studyhumansanalysis of serum of 227 IA patients, compared to 1096 from prospective databaseassociation of IgA and IgG against Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans with IA and SAHELISA- high IgA against P. gingivalis and A. actinomycetemcomitans increased the risk of IA and SAH significantly;
- high IgG levels against P. gingivalis and A. actinomycetemcomitans decreased the risk of IA and SAH significantly.
Hallikainen et al., 2023. [78]case–control, prospective studyhumansoral examination of 60 patients with UIA and 30 with RA compared to 5144 from prospective databaseassociation of caries with IA formation and SAHmultivariate logistic regression- caries does not increase the risk of IAs and SAH.
RA = ruptured intracranial aneurysm, UIA = unruptured intracranial aneurysm, SAH = subarachnoid hemorrhage, ICH = intracerebral hemorrhage, CES = cardioembolic stroke, qRT-PCR = real time quantitative polymerase chain reaction, STA = superficial temporal artery, MCA = middle meningeal artery, sp. = species (sg.), ssp. = species (pl.).
Pyysalo et al. [73] performed a dental examination of 89 patients before elective surgery for an IA. They detected gingiva pockets ≥6 mm as dental infection foci in 43% of patients. Moreover, total bacterial and Fusobacterium nucleatum DNA was significantly higher in patients with ≥6 mm gingival pockets than in patients without them. Nonetheless, it is important to note that these data do not permit us to draw any conclusion regarding a causal link between this observation and the formation of IAs.
In another study, Pyysalo et al. [71] detected DNA from endodontic and periodontal bacteria in 56% (20/36) and 47% (17/36) of tissue samples from ruptured IAs, respectively. The most frequently identified DNA belonged to the Streptococcus mitis group. Another study by Pyysalo et al. [72] found oral bacterial DNA in 69% (29/42) of ruptured and in 71% (20/28) of unruptured IA samples. Both tissue types contained significantly more bacterial DNA than control samples from non-atherosclerotic vessels walls. While these findings suggest a potential association between oral pathogens and IA formation, Aboukais et al. [75] could not detect bacterial DNA in any sample from ten ruptured and 20 unruptured IAs. A recently published review by Kennedy et al. [79] warns against interpreting studies with bacterial detection from low-biomass tissue. Their analysis of studies on the presence of bacteria in intrauterine prenatal tissue revealed that this is most likely contamination. Similarly, in the case of brain tissue, which is regarded as low-to-zero-biomass tissue, there is a high risk of results being distorted by contamination.
Hallikainen et al. [76] found that periodontitis was significantly associated with IAs and significantly increased the risk of SAH, while caries did not [78]. The association of periodontitis with the risk of IA formation and SAH was independent of gender, smoking status, hypertension, or alcohol abuse. The authors suggest the following mechanism: As periodontitis can accelerate the activation and mobilization of circulating neutrophils or monocytes, resulting in a generalized inflammatory response, it has the potential to influence the progression of cerebral artery remodeling and aneurysm pathology. This influence may render the artery more susceptible to aneurysm development and rupture. The lack of an association of caries with IAs and SAH could be explained by the fact that caries, contrary to periodontitis, does not predispose to bacteremia. In the case of periodontitis, there is a vulnerable surface of the gingiva that serves as an entry point for bacteria into the systemic circulation.
Another study by Hallikainen et al. [77] detected that serum IgA antibody levels against the two key periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, were significantly higher in patients with IAs compared to control patients. In a multivariate analysis, high IgA serum antibody levels against P. gingivalis and A. actinomycetemcomitans were significantly associated with a higher risk of IA formation and rupture, while IgG serum antibody levels against the same pathogens were significantly associated with a lower risk. Regarding this discrepancy, the authors provide the following rationale [77]: IgA levels predominantly signify recent or recurrent encounters with P. gingivalis and A. actinomycetemcomitans, whereas IgG levels are indicative of the development or triggering of an acquired immune response to these pathogens. Reduced IgG levels observed in IA patients may arise from several potential factors. One explanation is the capacity of P. gingivalis and A. actinomycetemcomitans to evade complement-mediated immune activation. Alternatively, it is conceivable that individuals may have developed immunity in response to prolonged pathogen exposure, without a concomitant increase in IgG levels. Furthermore, it is plausible that the quantity of circulating bacteria or bacterial metabolites/fragments may be insufficient to stimulate a significant elevation in IgG levels. Nonetheless, a limitation of this investigation lies in the exclusive measurement of IgA and IgG levels in serum, with no concurrent isolation of bacteria from the oral cavity. Furthermore, the study did not find any correlation between the clinical oral condition and the levels of serum antibodies.
Inenaga et al. [74] identified a significantly higher rate of Streptococcus mutans with collagen-binding protein, a bacterium with hemorrhagic characteristics, such as the activation of MMPs, in the saliva of patients with stroke, intracerebral hemorrhage, and ruptured intracranial aneurysm compared to a healthy control group. However, this was not a matched comparison, so the difference could be due to confounding factors.

5. Conclusions

The available evidence suggests that the gut and oral microbiome may play a role in the formation and rupture of IAs. Several studies have identified associations between oral and gut bacteria, periodontitis, gut microbiota depletion, unsaturated fatty acid biosynthesis, and IA pathophysiology. However, most studies are limited by a small sample size, the lack of matched controls, or are based on animal models, which hinder their ability to establish causality. The process of aneurysm formation in humans is complex and involves multiple factors, including genetics and exposure to risk factors. Animal aneurysm models are artificially generated and cannot reflect all these factors sufficiently.

6. Future Directions

In the field of chronic inflammatory bowel diseases and cancer, promising strategies have already emerged in the context of utilizing the microbiome [80,81]. Notably, fecal microbiota transplantation, which involves transferring fecal material containing distal gut microbiota from a healthy donor to a patient with an imbalanced gut microbiota, has been established as an effective therapy for recurrent Clostridioides difficile (former Clostridium difficile) colitis. Furthermore, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) has granted approval for the utilization of fecal microbiota transplantation in cases of recurrent diarrhea following antibiotic-associated diarrhea [80]. In the field of cancer research, there are numerous approaches to enhance the response to immunotherapy through the transplantation of various bacterial strains [81].
For IAs, further research is necessary to elucidate the exact mechanisms by which the gut and oral microbiome influence IA formation and rupture in humans. Prospective cohort studies and randomized controlled trials would provide higher-quality evidence for assessing these relationships. Moreover, the bias of contamination has to be addressed through a thorough experimental design. Understanding the role of the microbiome could potentially lead to new preventive strategies and therapeutic interventions for IAs.

Author Contributions

Conceptualization, M.W., V.R. and B.M.; methodology, A.-K.J.; data curation, A.-K.J.; writing—original draft preparation, A.-K.J. and M.W.; writing—review and editing, A.-K.J., M.W., B.M., C.A., A.W., K.N. and V.R.; supervision, M.W. and B.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are provided in the text.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Etminan, N.; Chang, H.S.; Hackenberg, K.; de Rooij, N.K.; Vergouwen, M.D.I.; Rinkel, G.J.E.; Algra, A. Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis. JAMA Neurol. 2019, 76, 588–597. [Google Scholar] [CrossRef]
  2. Suarez, J.I.; Tarr, R.W.; Selman, W.R. Aneurysmal subarachnoid hemorrhage. N. Engl. J. Med. 2006, 354, 387–396. [Google Scholar] [CrossRef] [PubMed]
  3. Johnston, S.C.; Selvin, S.; Gress, D.R. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998, 50, 1413–1418. [Google Scholar] [CrossRef] [PubMed]
  4. Van Gijn, J.; Kerr, R.S.; Rinkel, G.J. Subarachnoid haemorrhage. Lancet 2007, 369, 306–318. [Google Scholar] [CrossRef] [PubMed]
  5. Al-Khindi, T.; Macdonald, R.L.; Schweizer, T.A. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2010, 41, e519–e536. [Google Scholar] [CrossRef]
  6. Vlak, M.H.; Algra, A.; Brandenburg, R.; Rinkel, G.J. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol. 2011, 10, 626–636. [Google Scholar] [CrossRef]
  7. Juvela, S.; Poussa, K.; Lehto, H.; Porras, M. Natural history of unruptured intracranial aneurysms: A long-term follow-up study. Stroke 2013, 44, 2414–2421. [Google Scholar] [CrossRef]
  8. Wiebers, D.O.; Whisnant, J.P.; Huston, J., 3rd; Meissner, I.; Brown, R.D., Jr.; Piepgras, D.G.; Forbes, G.S.; Thielen, K.; Nichols, D.; O’Fallon, W.M.; et al. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003, 362, 103–110. [Google Scholar] [CrossRef]
  9. Tada, Y.; Wada, K.; Shimada, K.; Makino, H.; Liang, E.I.; Murakami, S.; Kudo, M.; Kitazato, K.T.; Nagahiro, S.; Hashimoto, T. Roles of hypertension in the rupture of intracranial aneurysms. Stroke 2014, 45, 579–586. [Google Scholar] [CrossRef]
  10. Gross, B.A.; Rosalind Lai, P.M.; Frerichs, K.U.; Du, R. Aspirin and aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014, 82, 1127–1130. [Google Scholar] [CrossRef]
  11. Hostettler, I.C.; Alg, V.S.; Shahi, N.; Jichi, F.; Bonner, S.; Walsh, D.; Bulters, D.; Kitchen, N.; Brown, M.M.; Houlden, H.; et al. Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case-Control Study. Neurosurgery 2017, 83, 43–52. [Google Scholar] [CrossRef]
  12. Vlak, M.H.; Rinkel, G.J.; Greebe, P.; Algra, A. Risk of rupture of an intracranial aneurysm based on patient characteristics: A case-control study. Stroke 2013, 44, 1256–1259. [Google Scholar] [CrossRef]
  13. Schatlo, B.; Gautschi, O.P.; Friedrich, C.M.; Ebeling, C.; Jagersberg, M.; Kulcsar, Z.; Pereira, V.M.; Schaller, K.; Bijlenga, P. Association of single and multiple aneurysms with tobacco abuse: An @neurIST risk analysis. Neurosurg. Focus 2019, 47, E9. [Google Scholar] [CrossRef]
  14. Morel, S.; Diagbouga, M.R.; Dupuy, N.; Sutter, E.; Braunersreuther, V.; Pelli, G.; Corniola, M.; Gondar, R.; Jagersberg, M.; Isidor, N.; et al. Correlating Clinical Risk Factors and Histological Features in Ruptured and Unruptured Human Intracranial Aneurysms: The Swiss AneuX Study. J. Neuropathol. Exp. Neurol. 2018, 77, 555–566. [Google Scholar] [CrossRef]
  15. Schatlo, B.; Fung, C.; Stienen, M.N.; Fathi, A.R.; Fandino, J.; Smoll, N.R.; Zumofen, D.; Daniel, R.T.; Burkhardt, J.K.; Bervini, D.; et al. Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS). Stroke 2021, 52, 344–347. [Google Scholar] [CrossRef]
  16. Ascher, S.; Reinhardt, C. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease. Eur. J. Immunol. 2018, 48, 564–575. [Google Scholar] [CrossRef] [PubMed]
  17. Benakis, C.; Brea, D.; Caballero, S.; Faraco, G.; Moore, J.; Murphy, M.; Sita, G.; Racchumi, G.; Ling, L.; Pamer, E.G.; et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat. Med. 2016, 22, 516–523. [Google Scholar] [CrossRef]
  18. Li, N.; Wang, X.; Sun, C.; Wu, X.; Lu, M.; Si, Y.; Ye, X.; Wang, T.; Yu, X.; Zhao, X.; et al. Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiol. 2019, 19, 191. [Google Scholar] [CrossRef] [PubMed]
  19. Nam, H.S. Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide. J. Stroke 2019, 21, 151–159. [Google Scholar] [CrossRef]
  20. Yin, J.; Liao, S.X.; He, Y.; Wang, S.; Xia, G.H.; Liu, F.T.; Zhu, J.J.; You, C.; Chen, Q.; Zhou, L.; et al. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. J. Am. Heart Assoc. 2015, 4, e002699. [Google Scholar] [CrossRef] [PubMed]
  21. Benson, T.W.; Conrad, K.A.; Li, X.S.; Wang, Z.; Helsley, R.N.; Schugar, R.C.; Coughlin, T.M.; Wadding-Lee, C.; Fleifil, S.; Russell, H.M.; et al. Gut Microbiota-Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms. Circulation 2023, 147, 1079–1096. [Google Scholar] [CrossRef]
  22. Nakayama, K.; Furuyama, T.; Matsubara, Y.; Morisaki, K.; Onohara, T.; Ikeda, T.; Yoshizumi, T. Gut dysbiosis and bacterial translocation in the aneurysmal wall and blood in patients with abdominal aortic aneurysm. PLoS ONE 2022, 17, e0278995. [Google Scholar] [CrossRef] [PubMed]
  23. El-Sayed, A.; Aleya, L.; Kamel, M. Microbiota’s role in health and diseases. Environ. Sci. Pollut. Res. 2021, 28, 36967–36983. [Google Scholar] [CrossRef] [PubMed]
  24. De Lorgeril, M.; Salen, P.; Martin, J.L.; Monjaud, I.; Delaye, J.; Mamelle, N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 1999, 99, 779–785. [Google Scholar] [CrossRef] [PubMed]
  25. Koeth, R.A.; Wang, Z.; Levison, B.S.; Buffa, J.A.; Org, E.; Sheehy, B.T.; Britt, E.B.; Fu, X.; Wu, Y.; Li, L.; et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19, 576–585. [Google Scholar] [CrossRef] [PubMed]
  26. Wang, Z.; Klipfell, E.; Bennett, B.J.; Koeth, R.; Levison, B.S.; Dugar, B.; Feldstein, A.E.; Britt, E.B.; Fu, X.; Chung, Y.M.; et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472, 57–63. [Google Scholar] [CrossRef] [PubMed]
  27. Manabe, Y.; Ishibashi, T.; Asano, R.; Tonomura, S.; Maeda, Y.; Motooka, D.; Ueda, J.; Yanagawa, M.; Edamoto-Taira, Y.; Chikaishi-Kirino, T.; et al. Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis. Arthritis Res. Ther. 2023, 25, 46. [Google Scholar] [CrossRef]
  28. Shinohara, R.; Nakashima, H.; Emoto, T.; Yamashita, T.; Saito, Y.; Yoshida, N.; Inoue, T.; Yamanaka, K.; Okada, K.; Hirata, K.I. Gut Microbiota Influence the Development of Abdominal Aortic Aneurysm by Suppressing Macrophage Accumulation in Mice. Hypertension 2022, 79, 2821–2829. [Google Scholar] [CrossRef]
  29. Xie, J.; Lu, W.; Zhong, L.; Hu, Y.; Li, Q.; Ding, R.; Zhong, Z.; Liu, Z.; Xiao, H.; Xie, D.; et al. Alterations in gut microbiota of abdominal aortic aneurysm mice. BMC Cardiovasc. Disord. 2020, 20, 32. [Google Scholar] [CrossRef]
  30. Fung, T.C.; Olson, C.A.; Hsiao, E.Y. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 2017, 20, 145–155. [Google Scholar] [CrossRef]
  31. Hasan, D.M.; Mahaney, K.B.; Brown, R.D., Jr.; Meissner, I.; Piepgras, D.G.; Huston, J.; Capuano, A.W.; Torner, J.C.; International Study of Unruptured Intracranial Aneurysms Investigators. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011, 42, 3156–3162. [Google Scholar] [CrossRef] [PubMed]
  32. Kanematsu, Y.; Kanematsu, M.; Kurihara, C.; Tada, Y.; Tsou, T.L.; van Rooijen, N.; Lawton, M.T.; Young, W.L.; Liang, E.I.; Nuki, Y.; et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 2011, 42, 173–178. [Google Scholar] [CrossRef] [PubMed]
  33. Chalouhi, N.; Hoh, B.L.; Hasan, D. Review of cerebral aneurysm formation, growth, and rupture. Stroke 2013, 44, 3613–3622. [Google Scholar] [CrossRef]
  34. Chalouhi, N.; Ali, M.S.; Jabbour, P.M.; Tjoumakaris, S.I.; Gonzalez, L.F.; Rosenwasser, R.H.; Koch, W.J.; Dumont, A.S. Biology of intracranial aneurysms: Role of inflammation. J. Cereb. Blood Flow Metab. 2012, 32, 1659–1676. [Google Scholar] [CrossRef]
  35. Jamous, M.A.; Nagahiro, S.; Kitazato, K.T.; Tamura, T.; Aziz, H.A.; Shono, M.; Satoh, K. Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: Experimental study in rats. J. Neurosurg. 2007, 107, 405–411. [Google Scholar] [CrossRef] [PubMed]
  36. Sho, E.; Sho, M.; Singh, T.M.; Nanjo, H.; Komatsu, M.; Xu, C.; Masuda, H.; Zarins, C.K. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp. Mol. Pathol. 2002, 73, 142–153. [Google Scholar] [CrossRef] [PubMed]
  37. Meng, H.; Wang, Z.; Hoi, Y.; Gao, L.; Metaxa, E.; Swartz, D.D.; Kolega, J. Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke 2007, 38, 1924–1931. [Google Scholar] [CrossRef]
  38. Mohan, S.; Mohan, N.; Sprague, E.A. Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments. Am. J. Physiol. 1997, 273, C572–C578. [Google Scholar] [CrossRef]
  39. Kadirvel, R.; Ding, Y.H.; Dai, D.; Zakaria, H.; Robertson, A.M.; Danielson, M.A.; Lewis, D.A.; Cloft, H.J.; Kallmes, D.F. The influence of hemodynamic forces on biomarkers in the walls of elastase-induced aneurysms in rabbits. Neuroradiology 2007, 49, 1041–1053. [Google Scholar] [CrossRef]
  40. Wang, Z.; Kolega, J.; Hoi, Y.; Gao, L.; Swartz, D.D.; Levy, E.I.; Mocco, J.; Meng, H. Molecular alterations associated with aneurysmal remodeling are localized in the high hemodynamic stress region of a created carotid bifurcation. Neurosurgery 2009, 65, 169–178. [Google Scholar] [CrossRef]
  41. Aoki, T.; Kataoka, H.; Nishimura, M.; Ishibashi, R.; Morishita, R.; Miyamoto, S. Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Gene Ther. 2010, 17, 1117–1123. [Google Scholar] [CrossRef] [PubMed]
  42. Aoki, T.; Kataoka, H.; Morimoto, M.; Nozaki, K.; Hashimoto, N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007, 38, 162–169. [Google Scholar] [CrossRef] [PubMed]
  43. Aoki, T.; Kataoka, H.; Ishibashi, R.; Nozaki, K.; Egashira, K.; Hashimoto, N. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 2009, 40, 942–951. [Google Scholar] [CrossRef] [PubMed]
  44. Frosen, J.; Piippo, A.; Paetau, A.; Kangasniemi, M.; Niemela, M.; Hernesniemi, J.; Jaaskelainen, J. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: Histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004, 35, 2287–2293. [Google Scholar] [CrossRef] [PubMed]
  45. Ishibashi, R.; Aoki, T.; Nishimura, M.; Hashimoto, N.; Miyamoto, S. Contribution of mast cells to cerebral aneurysm formation. Curr. Neurovasc. Res. 2010, 7, 113–124. [Google Scholar] [CrossRef] [PubMed]
  46. Merei, F.T.; Gallyas, F. Role of the structural elements of the arterial wall in the formation and growth of intracranial saccular aneurysms. Neurol. Res. 1980, 2, 283–303. [Google Scholar] [CrossRef] [PubMed]
  47. Tronc, F.; Mallat, Z.; Lehoux, S.; Wassef, M.; Esposito, B.; Tedgui, A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: Interaction with NO. Arterioscler. Thromb. Vasc. Biol. 2000, 20, E120–E126. [Google Scholar] [CrossRef]
  48. El-Hakim, Y.; Mani, K.K.; Eldouh, A.; Pandey, S.; Grimaldo, M.T.; Dabney, A.; Pilla, R.; Sohrabji, F. Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats. Biol. Sex Differ. 2021, 12, 14. [Google Scholar] [CrossRef]
  49. Zou, X.; Wang, L.; Xiao, L.; Wang, S.; Zhang, L. Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Front. Immunol. 2022, 13, 975921. [Google Scholar] [CrossRef]
  50. Kurita, N.; Yamashiro, K.; Kuroki, T.; Tanaka, R.; Urabe, T.; Ueno, Y.; Miyamoto, N.; Takanashi, M.; Shimura, H.; Inaba, T.; et al. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2020, 40, 2505–2520. [Google Scholar] [CrossRef]
  51. Yu, X.; Zhou, G.; Shao, B.; Zhou, H.; Xu, C.; Yan, F.; Wang, L.; Chen, G.; Li, J.; Fu, X. Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice. Front. Microbiol. 2021, 12, 647304. [Google Scholar] [CrossRef]
  52. Shikata, F.; Shimada, K.; Sato, H.; Ikedo, T.; Kuwabara, A.; Furukawa, H.; Korai, M.; Kotoda, M.; Yokosuka, K.; Makino, H.; et al. Potential Influences of Gut Microbiota on the Formation of Intracranial Aneurysm. Hypertension 2019, 73, 491–496. [Google Scholar] [CrossRef] [PubMed]
  53. Frosen, J.; Hallikainen, J.; Pyysalo, M.; Koivisto, T.; Lindgren, A. Letter by Frosen et al. Regarding Article “Potential Influences of Gut Microbiota on the Formation of Intracranial Aneurysm”. Hypertension 2019, 74, e22–e23. [Google Scholar] [CrossRef] [PubMed]
  54. Bharti, R.; Grimm, D.G. Current challenges and best-practice protocols for microbiome analysis. Brief. Bioinform. 2021, 22, 178–193. [Google Scholar] [CrossRef] [PubMed]
  55. Tringe, S.G.; Hugenholtz, P. A renaissance for the pioneering 16S rRNA gene. Curr. Opin. Microbiol. 2008, 11, 442–446. [Google Scholar] [CrossRef]
  56. Abellan-Schneyder, I.; Matchado, M.S.; Reitmeier, S.; Sommer, A.; Sewald, Z.; Baumbach, J.; List, M.; Neuhaus, K. Primer, Pipelines, Parameters: Issues in 16S rRNA Gene Sequencing. mSphere 2021, 6, e01202–e01220. [Google Scholar] [CrossRef]
  57. Benítez-Páez, A.; Portune, K.J.; Sanz, Y. Species-level resolution of 16S rRNA gene amplicons sequenced through the MinION™ portable nanopore sequencer. Gigascience 2016, 5, s13742-016. [Google Scholar] [CrossRef]
  58. Reitmeier, S.; Kiessling, S.; Clavel, T.; List, M.; Almeida, E.L.; Ghosh, T.G.; Neuhaus, K.; Troll, M.; Grallert, H.; Rathmann, W. Arrhythmic gut microbiome signatures risk profiling of Type-2 Diabetes. Cell Host Microbe 2020, 28, 258–272. [Google Scholar] [CrossRef]
  59. Salter, S.J.; Cox, M.J.; Turek, E.M.; Calus, S.T.; Cookson, W.O.; Moffatt, M.F.; Turner, P.; Parkhill, J.; Loman, N.J.; Walker, A.W. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014, 12, 87. [Google Scholar] [CrossRef]
  60. Kim, D.; Hofstaedter, C.E.; Zhao, C.; Mattei, L.; Tanes, C.; Clarke, E.; Lauder, A.; Sherrill-Mix, S.; Chehoud, C.; Kelsen, J. Optimizing methods and dodging pitfalls in microbiome research. Microbiome 2017, 5, 52. [Google Scholar] [CrossRef]
  61. De Goffau, M.C.; Lager, S.; Sovio, U.; Gaccioli, F.; Cook, E.; Peacock, S.J.; Parkhill, J.; Charnock-Jones, D.S.; Smith, G.C. Human placenta has no microbiome but can contain potential pathogens. Nature 2019, 572, 329–334. [Google Scholar] [CrossRef]
  62. Chu, Y.; Sun, S.; Huang, Y.; Gao, Q.; Xie, X.; Wang, P.; Li, J.; Liang, L.; He, X.; Jiang, Y. Metagenomic analysis revealed the potential role of gut microbiome in gout. NPJ Biofilms Microbiomes 2021, 7, 66. [Google Scholar] [CrossRef] [PubMed]
  63. Vanni, C.; Schechter, M.S.; Acinas, S.G.; Barberán, A.; Buttigieg, P.L.; Casamayor, E.O.; Delmont, T.O.; Duarte, C.M.; Eren, A.M.; Finn, R.D. Unifying the known and unknown microbial coding sequence space. eLife 2022, 11, e67667. [Google Scholar] [CrossRef] [PubMed]
  64. Zeng, X.; Gao, X.; Peng, Y.; Wu, Q.; Zhu, J.; Tan, C.; Xia, G.; You, C.; Xu, R.; Pan, S.; et al. Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut. Front. Cell. Infect. Microbiol. 2019, 9, 4. [Google Scholar] [CrossRef] [PubMed]
  65. Li, H.; Xu, H.; Li, Y.; Jiang, Y.; Hu, Y.; Liu, T.; Tian, X.; Zhao, X.; Zhu, Y.; Wang, S.; et al. Alterations of gut microbiota contribute to the progression of unruptured intracranial aneurysms. Nat. Commun. 2020, 11, 3218. [Google Scholar] [CrossRef] [PubMed]
  66. Kawabata, S.; Takagaki, M.; Nakamura, H.; Oki, H.; Motooka, D.; Nakamura, S.; Nishida, T.; Terada, E.; Izutsu, N.; Takenaka, T.; et al. Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms. Stroke 2022, 53, 895–903. [Google Scholar] [CrossRef] [PubMed]
  67. He, M.; Wang, W.; He, Q.; Dai, H.; Han, J.; Cui, W. Genetic Causal Association Between the Gut Microbiome and Intracranial Aneurysm and Subarachnoid Hemorrhage: A Two-Sample Mendelian Randomization Study. Neurol. Ther. 2023, 12, 1695–1707. [Google Scholar] [CrossRef] [PubMed]
  68. Ma, C.; Zhang, W.; Mao, L.; Zhang, G.; Shen, Y.; Chang, H.; Xu, X.; Jin, H.; Li, Z.; Lu, H. Association of gut microbiome with risk of intracranial aneurysm: A Mendelian randomization study. BMC Neurol. 2023, 23, 269. [Google Scholar] [CrossRef]
  69. Butchart, D.G.; Grieve, A.R.; Kamel, J.H. The retention in dentine and composite resin materials of Bondent dentine pins. Br. Dent. J. 1988, 165, 165–169. [Google Scholar] [CrossRef]
  70. Metwaly, A.; Reitmeier, S.; Haller, D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 383–397. [Google Scholar] [CrossRef]
  71. Pyysalo, M.J.; Pyysalo, L.M.; Pessi, T.; Karhunen, P.J.; Ohman, J.E. The connection between ruptured cerebral aneurysms and odontogenic bacteria. J. Neurol. Neurosurg. Psychiatry 2013, 84, 1214–1218. [Google Scholar] [CrossRef] [PubMed]
  72. Pyysalo, M.J.; Pyysalo, L.M.; Pessi, T.; Karhunen, P.J.; Lehtimaki, T.; Oksala, N.; Ohman, J.E. Bacterial DNA findings in ruptured and unruptured intracranial aneurysms. Acta Odontol. Scand. 2016, 74, 315–320. [Google Scholar] [CrossRef] [PubMed]
  73. Pyysalo, M.J.; Pyysalo, L.M.; Hiltunen, J.; Jarnstedt, J.; Helminen, M.; Karhunen, P.J.; Pessi, T. The dental infections in patients undergoing preoperative dental examination before surgical treatment of saccular intracranial aneurysm. BMC Res. Notes 2018, 11, 600. [Google Scholar] [CrossRef]
  74. Inenaga, C.; Hokamura, K.; Nakano, K.; Nomura, R.; Naka, S.; Ohashi, T.; Ooshima, T.; Kuriyama, N.; Hamasaki, T.; Wada, K.; et al. A Potential New Risk Factor for Stroke: Streptococcus Mutans With Collagen-Binding Protein. World Neurosurg. 2018, 113, e77–e81. [Google Scholar] [CrossRef] [PubMed]
  75. Aboukais, R.; Loiez, C.; Leclerc, X.; Bourgeois, P.; Wallet, F.; Menovsky, T.; Lejeune, J.P. Absence of bacteria in intracranial aneurysms. J. Neurosurg. 2019, 132, 1197–1201. [Google Scholar] [CrossRef]
  76. Hallikainen, J.; Lindgren, A.; Savolainen, J.; Selander, T.; Jula, A.; Narhi, M.; Koivisto, T.; Kellokoski, J.; Ylostalo, P.; Suominen, A.L.; et al. Periodontitis and gingival bleeding associate with intracranial aneurysms and risk of aneurysmal subarachnoid hemorrhage. Neurosurg. Rev. 2020, 43, 669–679. [Google Scholar] [CrossRef] [PubMed]
  77. Hallikainen, J.; Pyysalo, M.; Keranen, S.; Kellokoski, J.; Koivisto, T.; Suominen, A.L.; Pussinen, P.; Pessi, T.; Frosen, J. Systemic immune response against the oral pathogens Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans is associated with the formation and rupture of intracranial aneurysms. Eur. J. Neurol. 2021, 28, 3089–3099. [Google Scholar] [CrossRef]
  78. Hallikainen, J.; Pessi, T.; Vehkalahti, M.; Suominen, A.L.; Pyysalo, M.; Frosen, J. Unlike severe periodontitis, caries does not associate with intracranial aneurysms or aneurysmal subarachnoid hemorrhage. Acta Neurochir. 2023, 165, 169–175. [Google Scholar] [CrossRef]
  79. Kennedy, K.M.; de Goffau, M.C.; Perez-Munoz, M.E.; Arrieta, M.C.; Backhed, F.; Bork, P.; Braun, T.; Bushman, F.D.; Dore, J.; de Vos, W.M.; et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature 2023, 613, 639–649. [Google Scholar] [CrossRef]
  80. Vieira, A.T.; Fukumori, C.; Ferreira, C.M. New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin. Transl. Immunol. 2016, 5, e87. [Google Scholar] [CrossRef]
  81. Soto Chervin, C.; Gajewski, T.F. Microbiome-based interventions: Therapeutic strategies in cancer immunotherapy. Immuno-Oncol. Technol. 2020, 8, 12–20. [Google Scholar] [CrossRef] [PubMed]
Ijms 25 00048 g001
Figure 1. Gut–brain interaction. Figure shows a potential mechanism of gut–brain interaction. Gut dysbiosis leads to dysregulation of the gut–blood barrier and LPS translocation to systemic circulation, consecutively activating the immune system. The immune cells enter the intracranial vessels through the systemic circulation and exert stress on the vascular endothelium here through inflammatory mediators. TLR = Toll-like receptor, IL = interleukin, TNF = tumor necrosis factor, iNOS = inducible nitric oxide synthase, IFN = interferon. Created with BioRender.com.
Figure 1. Gut–brain interaction. Figure shows a potential mechanism of gut–brain interaction. Gut dysbiosis leads to dysregulation of the gut–blood barrier and LPS translocation to systemic circulation, consecutively activating the immune system. The immune cells enter the intracranial vessels through the systemic circulation and exert stress on the vascular endothelium here through inflammatory mediators. TLR = Toll-like receptor, IL = interleukin, TNF = tumor necrosis factor, iNOS = inducible nitric oxide synthase, IFN = interferon. Created with BioRender.com.
Ijms 25 00048 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Joerger, A.-K.; Albrecht, C.; Rothhammer, V.; Neuhaus, K.; Wagner, A.; Meyer, B.; Wostrack, M. The Role of Gut and Oral Microbiota in the Formation and Rupture of Intracranial Aneurysms: A Literature Review. Int. J. Mol. Sci. 2024, 25, 48. https://doi.org/10.3390/ijms25010048

AMA Style

Joerger A-K, Albrecht C, Rothhammer V, Neuhaus K, Wagner A, Meyer B, Wostrack M. The Role of Gut and Oral Microbiota in the Formation and Rupture of Intracranial Aneurysms: A Literature Review. International Journal of Molecular Sciences. 2024; 25(1):48. https://doi.org/10.3390/ijms25010048

Chicago/Turabian Style

Joerger, Ann-Kathrin, Carolin Albrecht, Veit Rothhammer, Klaus Neuhaus, Arthur Wagner, Bernhard Meyer, and Maria Wostrack. 2024. "The Role of Gut and Oral Microbiota in the Formation and Rupture of Intracranial Aneurysms: A Literature Review" International Journal of Molecular Sciences 25, no. 1: 48. https://doi.org/10.3390/ijms25010048

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop